| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206.
|
Mol Biol Cell
|
1998
|
2.24
|
|
2
|
Human mast cells produce IL-8.
|
J Immunol
|
1993
|
1.44
|
|
3
|
Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling.
|
FASEB J
|
2000
|
1.26
|
|
4
|
E- and P-cadherin expression during murine hair follicle morphogenesis and cycling.
|
Exp Dermatol
|
1999
|
1.22
|
|
5
|
Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior.
|
J Invest Dermatol
|
1998
|
1.06
|
|
6
|
Phenotypic evaluation of cultured human mast and basophilic cells and of normal human skin mast cells.
|
Arch Dermatol Res
|
1994
|
1.02
|
|
7
|
Transforming growth factor-beta receptor type I and type II expression during murine hair follicle development and cycling.
|
J Invest Dermatol
|
1997
|
1.01
|
|
8
|
Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes.
|
Arch Dermatol Res
|
1994
|
0.98
|
|
9
|
A role for p75 neurotrophin receptor in the control of apoptosis-driven hair follicle regression.
|
FASEB J
|
2000
|
0.98
|
|
10
|
Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 act as "epitheliotrophins" in murine skin.
|
Lab Invest
|
1999
|
0.97
|
|
11
|
Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists.
|
Exp Dermatol
|
2000
|
0.97
|
|
12
|
Mast cells and vasculature in atopic dermatitis--potential stimulus of neoangiogenesis.
|
Allergy
|
2005
|
0.97
|
|
13
|
A new role for neurotrophin-3: involvement in the regulation of hair follicle regression (catagen).
|
Am J Pathol
|
1998
|
0.94
|
|
14
|
Human skin mast cells rapidly release preformed and newly generated TNF-alpha and IL-8 following stimulation with anti-IgE and other secretagogues.
|
Exp Dermatol
|
2001
|
0.94
|
|
15
|
Comparative cytokine release from human monocytes, monocyte-derived immature mast cells, and a human mast cell line (HMC-1).
|
J Invest Dermatol
|
1994
|
0.94
|
|
16
|
Mechanism of proline-specific proteinases: (I) Substrate specificity of dipeptidyl peptidase IV from pig kidney and proline-specific endopeptidase from Flavobacterium meningosepticum.
|
Biochim Biophys Acta
|
1988
|
0.93
|
|
17
|
A new role for neurotrophins: involvement of brain-derived neurotrophic factor and neurotrophin-4 in hair cycle control.
|
FASEB J
|
1999
|
0.93
|
|
18
|
Release of stem cell factor from a human keratinocyte line, HaCaT, is increased in differentiating versus proliferating cells.
|
J Invest Dermatol
|
1996
|
0.92
|
|
19
|
Neurotrophins act as neuroendocrine regulators of skin homeostasis in health and disease.
|
Horm Metab Res
|
2007
|
0.91
|
|
20
|
The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils.
|
J Allergy Clin Immunol
|
2001
|
0.88
|
|
21
|
New roles for glial cell line-derived neurotrophic factor and neurturin: involvement in hair cycle control.
|
Am J Pathol
|
2000
|
0.87
|
|
22
|
High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy, decreases IgE-binding cells in lesional skin of patients with atopic eczema.
|
J Invest Dermatol
|
1996
|
0.82
|
|
23
|
Expression of mast cell growth modulating and chemotactic factors and their receptors in human cutaneous scars.
|
J Invest Dermatol
|
2001
|
0.82
|
|
24
|
Altered expression of mast cell chymase and tryptase and of c-Kit in human cutaneous scar tissue.
|
J Invest Dermatol
|
2000
|
0.81
|
|
25
|
Aspirin-sensitive rhinitis-associated changes in upper airway innervation.
|
Eur Respir J
|
2003
|
0.78
|
|
26
|
Pan-neurotrophin receptor p75NTR expression is strongly induced in lesional atopic mast cells.
|
Clin Exp Allergy
|
2008
|
0.78
|
|
27
|
Induction of MHC class II antigen expression on human HMC-1 mast cells.
|
J Dermatol Sci
|
1997
|
0.77
|
|
28
|
Mast cells in the cytokine network: the what, where from and what for.
|
Exp Dermatol
|
1995
|
0.77
|
|
29
|
Intercellular adhesion molecule-1 and hair follicle regression.
|
J Histochem Cytochem
|
2000
|
0.77
|
|
30
|
Modulation of in vitro cytokine release from human leukemic mast cells (HMC-1) by glucocorticoids.
|
Skin Pharmacol
|
1996
|
0.77
|
|
31
|
Cell type-specific regulation of brain-derived neurotrophic factor in states of allergic inflammation.
|
Clin Exp Allergy
|
2007
|
0.76
|
|
32
|
Alterations in ganglioside expression during the differentiation of human mast cells.
|
Exp Dermatol
|
1999
|
0.76
|
|
33
|
Effect of granulocyte macrophage colony-stimulating factor in a patient with benign systemic mastocytosis.
|
Br J Dermatol
|
2001
|
0.76
|
|
34
|
Induction of human leukaemic mast cell differentiation by fibroblast supernatants, but not by stem cell factor.
|
Scand J Immunol
|
1998
|
0.75
|
|
35
|
Two novel mast cell phenotypic markers, monoclonal antibodies Ki-MC1 and Ki-M1P, identify distinct mast cell subtypes.
|
Br J Dermatol
|
1995
|
0.75
|
|
36
|
A computerized system for equipment control and preventive maintenance.
|
Med Instrum
|
1981
|
0.75
|
|
37
|
Similarities of the substrate cleavage catalyzed by proline specific endopeptidase and dipeptidyl peptidase IV.
|
Pharmazie
|
1984
|
0.75
|